PLRX - Pliant Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PLRX is currently covered by 9 analysts with an average price target of $19.35. This is a potential upside of $17.66 (1044.97%) from yesterday's end of day stock price of $1.69.

Pliant Therapeutics 's activity chart (see below) currently has 43 price targets and 88 ratings on display. The stock rating distribution of PLRX is 81.36% BUY and 18.64% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.47% with an average time for these price targets to be met of 62 days.

Highest price target for PLRX is $32, Lowest price target is $1.5, average price target is $17.08.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 18-Mar-2025. First documented stock forecast 29-Jun-2020.

Currently out of the existing stock ratings of PLRX, 48 are a BUY (81.36%), 11 are a HOLD (18.64%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1 months 15 days ago
(18-Mar-2025)

0/19 (0%)

$23 (153.33%)

Hold

1 months 29 days ago
(04-Mar-2025)

1/5 (20%)

$45.98 (270.15%)

199

Hold

$3

$1.54 (105.48%)

$4

1 months 29 days ago
(04-Mar-2025)

0/14 (0%)

$1.62 (117.39%)

Hold

$1.5

$0.04 (2.74%)

$4

1 months 29 days ago
(04-Mar-2025)

2/6 (33.33%)

$0.12 (8.70%)

74

Buy

$10

$8.54 (584.93%)

$10

1 months 29 days ago
(04-Mar-2025)

0/14 (0%)

$8.62 (624.64%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PLRX (Pliant Therapeutics ) average time for price targets to be met?

On average it took 62 days on average for the stock forecasts to be realized with a an average price target met ratio 13.47

Which analyst has the current highest performing score on PLRX (Pliant Therapeutics ) with a proven track record?

DAVID LEBOWITZ

Which analyst has the most public recommendations on PLRX (Pliant Therapeutics )?

David Lebowitz works at CITI and has 6 price targets and 6 ratings on PLRX

Which analyst is the currently most bullish on PLRX (Pliant Therapeutics )?

Joel Beatty with highest potential upside - $42.54

Which analyst is the currently most reserved on PLRX (Pliant Therapeutics )?

Pete Stavropoulos with lowest potential downside - -$0

Pliant Therapeutics  in the News

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

–  Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials –  Pliant will reduce its current workforce by approximately 45% –  Closing activities for BEACON-IPF trial ongoing; topline data expected in the second quarter of 2025 SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq:...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?